Syntax Research, Inc. Globus Medical Inc Transaction History
Syntax Research, Inc.
- $139 Billion
- Q4 2024
A detailed history of Syntax Research, Inc. transactions in Globus Medical Inc stock. As of the latest transaction made, Syntax Research, Inc. holds 1,000 shares of GMED stock, worth $73,910. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$73,910
Previous $71.5 Million
15.61%
% of portfolio
0.06%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding GMED
# of Institutions
538Shares Held
108MCall Options Held
295KPut Options Held
140K-
Vanguard Group Inc Valley Forge, PA10.9MShares$803 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$764 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X06.61MShares$489 Million0.29% of portfolio
-
State Street Corp Boston, MA3.59MShares$266 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.8MShares$207 Million0.02% of portfolio
About GLOBUS MEDICAL INC
- Ticker GMED
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 77,037,200
- Market Cap $5.69B
- Description
- Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...